1. A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial. (November 2022) Authors: Climent, Miguel A.; Font, Albert; Durán, Ignacio; Puente, Javier; José Méndez-Vidal, María; Sáez, María Isabel; Santander Lobera, Carmen; Ángel Arranz Arija, Jóse; González-del-Alba, Aranzazu; Sánchez-Hernandez, Alfredo; Juan Fita, Maria Jose; Esteban, Emilio; Alonso-Gordoa, Teresa; Mellado Gonza... Journal: European journal of cancer Issue: Volume 175(2022) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program. (September 2014) Authors: Castellano, Daniel; Antón Aparicio, Luis M; Esteban, Emilio; Sánchez-Hernández, Alfredo; Germà, Jose Ramón; Batista, Norberto; Maroto, Pablo; Pérez-Valderrama, Begoña; Luque, Raquel; Méndez-Vidal, María José Journal: Expert opinion on drug safety Issue: Volume 13:Number 9(2014) Page Start: 1165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cabozantinib combination therapy for the treatment of solid tumors: a systematic review. (July 2022) Authors: Castellano, Daniel; Apolo, Andrea B.; Porta, Camillo; Capdevila, Jaume; Viteri, Santiago; Rodriguez-Antona, Cristina; Martin, Lidia; Maroto, Pablo Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cabozantinib for the treatment of solid tumors: a systematic review. (June 2022) Authors: Maroto, Pablo; Porta, Camillo; Capdevila, Jaume; Apolo, Andrea B.; Viteri, Santiago; Rodriguez-Antona, Cristina; Martin, Lidia; Castellano, Daniel Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Docetaxel in prostate cancer: a familiar face as the new standard in a hormone-sensitive setting. (May 2017) Authors: Puente, Javier; Grande, Enrique; Medina, Ana; Maroto, Pablo; Lainez, Nuria; Arranz, Jose Angel Journal: Therapeutic advances in medical oncology Issue: Volume 9:Number 5(2017:Sep.) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ECCO Essential Requirements for Quality Cancer Care: Prostate cancer. (April 2020) Authors: Brausi, Maurizio; Hoskin, Peter; Andritsch, Elisabeth; Banks, Ian; Beishon, Marc; Boyle, Helen; Colecchia, Maurizio; Delgado-Bolton, Roberto; Höckel, Michael; Leonard, Kay; Lövey, József; Maroto, Pablo; Mastris, Ken; Medeiros, Rui; Naredi, Peter; Oyen, Raymond; de Reijke, Theo; Selby, Peter; Saar... Journal: Critical reviews in oncology/hematology Issue: Volume 148(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer. (April 2016) Authors: Maroto, Pablo; Solsona, Eduardo; Gallardo, Enrique; Mellado, Begoña; Morote, Juan; Arranz, José Ángel; Gómez-Veiga, Francisco; Unda, Miguel; Climent, Miguel Ángel; Alcaraz, Antonio Journal: Critical reviews in oncology/hematology Issue: Volume 100(2016) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer. (April 2016) Authors: Maroto, Pablo; Solsona, Eduardo; Gallardo, Enrique; Mellado, Begoña; Morote, Juan; Arranz, José Ángel; Gómez-Veiga, Francisco; Unda, Miguel; Climent, Miguel Ángel; Alcaraz, Antonio Journal: Critical reviews in oncology/hematology Issue: Volume 100(2016) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis. (December 2016) Authors: Escudier, Bernard; Molinie, Vincent; Bracarda, Sergio; Maroto, Pablo; Szczylik, Cezary; Nathan, Paul; Negrier, Sylvie; Weiss, Claudia; Porta, Camillo; Grünwald, Viktor; Albiges, Laurence Journal: European journal of cancer Issue: Volume 69(2016) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients. (26th January 2017) Authors: Gonzalez-Billalabeitia, Enrique; Castellano, Daniel; Sobrevilla, Nora; Guma, Josep; Hervas, David; Luengo, Maria I.; Aparicio, Jorge; Sanchez-Muñoz, Alfonso; Mellado, Begoña; Saenz, Alberto; Valverde, Claudia; Fernandez, Antonio; Margeli, Mireia; Duran, Ignacio; Fernandez, Sara; Sastre, Javier; R... Journal: Journal of the National Cancer Institute Issue: Volume 109:Number 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗